We are live on ! Find out more
INDV icon

Indivior Pharmaceuticals
INDV

259 hedge funds and large institutions have $4.36B invested in Indivior Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 90 funds opening new positions, 84 increasing their positions, 67 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,820% more call options, than puts

Call options by funds: $78M | Put options by funds: $4.07M

246% more first-time investments, than exits

New positions opened: 90 | Existing positions closed: 26

63% more capital invested

Capital invested by funds: $2.68B → $4.36B (+$1.68B)

31% more funds holding

Funds holding: 198 → 259 (+61)

25% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 67

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

Holders
259
Holders Change
+61
Holders Change %
+30.81%
% of All Funds
3.15%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
90
Increased
84
Reduced
67
Closed
26
Calls
$78M
Puts
$4.07M
Net Calls
+$74M
Net Calls Change
+$18.1M

Top Buyers

1
BlackRock
BlackRock
New York
+$290M
2
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$97.8M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$70.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$61.3M
5
State Street
State Street
Massachusetts
+$56.3M

Top Sellers

1
OCM
Oaktree Capital Management
California
-$7.65B
2
TSC
Two Seas Capital
New York
-$165M
3
DM
Deerfield Management
New York
-$110M
4
Goldman Sachs
Goldman Sachs
New York
-$104M
5
NM
Newtyn Management
New York
-$50.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
VRS
151
Virginia Retirement Systems
Virginia
$761K +$21.4K +700 +3%
SOW
152
State of Wyoming
Wyoming
$740K -$58.1K -1,902 -8%
CUAMC
153
China Universal Asset Management Company
China
$730K -$46.6K -1,525 -7%
IMC Chicago
154
IMC Chicago
Illinois
$716K +$609K +19,952 New
First Trust Advisors
155
First Trust Advisors
Illinois
$686K +$584K +19,120 New
Jennison Associates
156
Jennison Associates
New York
$685K +$583K +19,081 New
MSRPS
157
Maryland State Retirement & Pension System
Maryland
$655K +$558K +18,269 New
DP
158
Diadema Partners
New Jersey
$621K -$7.23M -236,932 -93%
HIS
159
Harvest Investment Services
Illinois
$609K +$518K +16,977 New
TC
160
TwinBeech Capital
New York
$593K +$504K +16,514 New
CFM
161
Catalyst Funds Management
Australia
$581K +$494K +16,180 New
Envestnet Asset Management
162
Envestnet Asset Management
Illinois
$575K +$77.3K +2,533 +19%
Pictet Asset Management
163
Pictet Asset Management
Switzerland
$538K -$5.82M -190,481 -93%
National Bank of Canada
164
National Bank of Canada
Quebec, Canada
$530K +$432K +14,136 +2,195%
MOACM
165
Mutual of America Capital Management
New York
$512K +$436K +14,270 New
EWA
166
EP Wealth Advisors
California
$481K +$410K +13,419 New
AIM
167
ARGA Investment Management
Connecticut
$473K – – –
IQI
168
Integrated Quantitative Investments
Washington
$468K +$398K +13,044 New
LCM
169
Legato Capital Management
California
$468K +$398K +13,044 New
Teacher Retirement System of Texas
170
Teacher Retirement System of Texas
Texas
$467K -$353K -11,564 -47%
EPIM
171
Evelyn Partners Investment Management
$454K – – –
PA
172
Profund Advisors
Maryland
$451K +$384K +12,569 New
Allspring Global Investments
173
Allspring Global Investments
North Carolina
$448K +$383K +12,532 New
FDP
174
Financiere des Professionnels
Quebec, Canada
$428K +$76.4K +2,502 +27%
VI
175
Vestcor Inc
New Brunswick, Canada
$397K – – –
5 6
7
8 9

INDV Hedge Fund Activity: Q4 2025 in Review

259 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Indivior Pharmaceuticals (INDV) for Q4 2025, worth a combined $4.36B — up 63% from $2.68B a quarter earlier.

Buyers outnumbered sellers: 90 funds opened new INDV positions and 26 closed out — a net gain of 64 holders — while 84 added to existing stakes and 67 trimmed.

The largest buyer was BlackRock, adding an estimated $290M. The largest seller was Oaktree Capital Management, cutting an estimated $7.65B.

  • 259 institutional investors held Indivior Pharmaceuticals (INDV) as of Q4 2025, up from 198 in Q3 2025.
  • Funds reported $4.36B of Indivior Pharmaceuticals stock for Q4 2025, up 63% quarter-over-quarter.
  • 90 funds opened new Indivior Pharmaceuticals positions in Q4 2025 and 26 closed out, a net change of +64 holders.
  • The largest Indivior Pharmaceuticals buyer in Q4 2025 was BlackRock, an estimated $290M added.
  • The largest Indivior Pharmaceuticals seller in Q4 2025 was Oaktree Capital Management, an estimated $7.65B sold.

Based on aggregated 13F filings for Q4 2025.